⌘K

Login Start Free

Home/Filings/4/0001209191-19-056745

4//SEC Filing

Friedman Bart 4

Accession 0001209191-19-056745

CIK 0001636651other

View on SEC.gov Company Profile

Filed

Nov 14, 7:00 PM ET

Accepted

Nov 15, 4:26 PM ET

Size

5.3 KB

Accession

0001209191-19-056745

Insider Transaction Report

Form 4

Period: 2019-11-13

Ovid Therapeutics Inc.OVID

Director

Transactions

Award
Stock Option (right to buy)
2019-11-13+7,437→ 7,437 total
Exercise: $2.43Exp: 2029-11-12→ Common Stock (7,437 underlying)

Footnotes (1)

[F1]The option will vest in full on November 13, 2020, subject to the Reporting Person's continuous service through such vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1

filerCIK 0001368324

Filing Metadata

Form type: 4
Filed: Nov 14, 7:00 PM ET
Accepted: Nov 15, 4:26 PM ET
Size: 5.3 KB

View on SEC.gov